middle.news

Iperion narrows loss with waived licence targets and secured loan facility

7:17am on Wednesday 1st of July, 2026 AEST Manufacturing
Read Story

Iperion narrows loss with waived licence targets and secured loan facility

7:17am on Wednesday 1st of July, 2026 AEST
Key Points
  • Net loss reduced to $294,595 from $455,683 prior year
  • No sales revenue recorded; Pathoglaze development ongoing
  • $400,000 manufacturing plant fee fully discounted through 2028
  • Licence performance targets permanently waived
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Iperion (NZX:IPR)
OPEN ARTICLE